TW202348221A - Cosmetic composition with skin microbiome-friendly properties - Google Patents
Cosmetic composition with skin microbiome-friendly properties Download PDFInfo
- Publication number
- TW202348221A TW202348221A TW112120414A TW112120414A TW202348221A TW 202348221 A TW202348221 A TW 202348221A TW 112120414 A TW112120414 A TW 112120414A TW 112120414 A TW112120414 A TW 112120414A TW 202348221 A TW202348221 A TW 202348221A
- Authority
- TW
- Taiwan
- Prior art keywords
- oil
- polyglyceryl
- group
- skin
- composition according
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 118
- 239000002537 cosmetic Substances 0.000 title claims abstract description 64
- 230000009286 beneficial effect Effects 0.000 claims abstract description 72
- 241000894006 Bacteria Species 0.000 claims abstract description 68
- 244000005700 microbiome Species 0.000 claims abstract description 30
- 244000005714 skin microbiome Species 0.000 claims abstract description 19
- 239000003921 oil Substances 0.000 claims description 70
- 235000019198 oils Nutrition 0.000 claims description 70
- 239000004094 surface-active agent Substances 0.000 claims description 54
- 150000003904 phospholipids Chemical class 0.000 claims description 26
- 239000002202 Polyethylene glycol Substances 0.000 claims description 23
- 229920001223 polyethylene glycol Polymers 0.000 claims description 23
- -1 alkyl glucoside Chemical class 0.000 claims description 19
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 19
- 239000000194 fatty acid Substances 0.000 claims description 19
- 229930195729 fatty acid Natural products 0.000 claims description 19
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 19
- 150000004665 fatty acids Chemical class 0.000 claims description 17
- 229940049964 oleate Drugs 0.000 claims description 16
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 229930182478 glucoside Natural products 0.000 claims description 14
- 241000191963 Staphylococcus epidermidis Species 0.000 claims description 13
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 13
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 claims description 13
- 230000002708 enhancing effect Effects 0.000 claims description 13
- 229940070765 laurate Drugs 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 12
- 239000010696 ester oil Substances 0.000 claims description 9
- 229930195733 hydrocarbon Natural products 0.000 claims description 9
- 150000002430 hydrocarbons Chemical class 0.000 claims description 9
- 239000002736 nonionic surfactant Substances 0.000 claims description 9
- 239000004215 Carbon black (E152) Substances 0.000 claims description 8
- 240000007817 Olea europaea Species 0.000 claims description 8
- SWQUTKGVXGTROS-UHFFFAOYSA-N bis(2-ethoxyethyl) butanedioate Chemical compound CCOCCOC(=O)CCC(=O)OCCOCC SWQUTKGVXGTROS-UHFFFAOYSA-N 0.000 claims description 8
- 229940119676 diethoxyethyl succinate Drugs 0.000 claims description 8
- 239000002562 thickening agent Substances 0.000 claims description 8
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 claims description 7
- 229920002545 silicone oil Polymers 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 claims description 6
- 239000004472 Lysine Substances 0.000 claims description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 6
- 244000025272 Persea americana Species 0.000 claims description 6
- 235000021302 avocado oil Nutrition 0.000 claims description 6
- 239000008163 avocado oil Substances 0.000 claims description 6
- 229940008099 dimethicone Drugs 0.000 claims description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 6
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 claims description 6
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 claims description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 6
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 6
- 239000008213 purified water Substances 0.000 claims description 6
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 claims description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 5
- 244000075850 Avena orientalis Species 0.000 claims description 5
- 235000007319 Avena orientalis Nutrition 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- 229920001202 Inulin Polymers 0.000 claims description 5
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 5
- JNFDQAYPZCYWLD-UHFFFAOYSA-N bis[2-(2-ethoxyethoxy)ethyl] cyclohexane-1,4-dicarboxylate Chemical compound CCOCCOCCOC(=O)C1CCC(C(=O)OCCOCCOCC)CC1 JNFDQAYPZCYWLD-UHFFFAOYSA-N 0.000 claims description 5
- 229940083913 c14-22 alcohols Drugs 0.000 claims description 5
- PXGZQGDTEZPERC-UHFFFAOYSA-L cyclohexane-1,4-dicarboxylate Chemical compound [O-]C(=O)C1CCC(C([O-])=O)CC1 PXGZQGDTEZPERC-UHFFFAOYSA-L 0.000 claims description 5
- CNRDTAOOANTPCG-UHFFFAOYSA-N dodecyl carbamate Chemical compound CCCCCCCCCCCCOC(N)=O CNRDTAOOANTPCG-UHFFFAOYSA-N 0.000 claims description 5
- 150000008131 glucosides Chemical class 0.000 claims description 5
- BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims description 5
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 5
- 229940029339 inulin Drugs 0.000 claims description 5
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 claims description 5
- 238000012423 maintenance Methods 0.000 claims description 5
- 239000004006 olive oil Substances 0.000 claims description 5
- 235000008390 olive oil Nutrition 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 claims description 4
- 244000020551 Helianthus annuus Species 0.000 claims description 4
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 4
- 235000002725 Olea europaea Nutrition 0.000 claims description 4
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 4
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 4
- 239000004359 castor oil Substances 0.000 claims description 4
- 235000019438 castor oil Nutrition 0.000 claims description 4
- 229920006037 cross link polymer Polymers 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 4
- KIIMXLPXYAXWRS-UHFFFAOYSA-N heptyl undec-2-enoate Chemical compound CCCCCCCCC=CC(=O)OCCCCCCC KIIMXLPXYAXWRS-UHFFFAOYSA-N 0.000 claims description 4
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 4
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 claims description 4
- IIYFAKIEWZDVMP-UHFFFAOYSA-N tridecane Chemical compound CCCCCCCCCCCCC IIYFAKIEWZDVMP-UHFFFAOYSA-N 0.000 claims description 4
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 claims description 4
- 239000000230 xanthan gum Substances 0.000 claims description 4
- 229920001285 xanthan gum Polymers 0.000 claims description 4
- 235000010493 xanthan gum Nutrition 0.000 claims description 4
- 229940082509 xanthan gum Drugs 0.000 claims description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 3
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 claims description 3
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- 235000021357 Behenic acid Nutrition 0.000 claims description 3
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 3
- 235000008673 Persea americana Nutrition 0.000 claims description 3
- 235000011236 Persea americana var americana Nutrition 0.000 claims description 3
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 claims description 3
- 244000044822 Simmondsia californica Species 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 125000005250 alkyl acrylate group Chemical group 0.000 claims description 3
- 229940116226 behenic acid Drugs 0.000 claims description 3
- 229960000541 cetyl alcohol Drugs 0.000 claims description 3
- 229960000735 docosanol Drugs 0.000 claims description 3
- 238000004945 emulsification Methods 0.000 claims description 3
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- DMMXZLMYEUEJFT-UHFFFAOYSA-N ethyl 16-methylheptadecanoate Chemical compound CCOC(=O)CCCCCCCCCCCCCCC(C)C DMMXZLMYEUEJFT-UHFFFAOYSA-N 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- 229940101267 panthenol Drugs 0.000 claims description 3
- 235000020957 pantothenol Nutrition 0.000 claims description 3
- 239000011619 pantothenol Substances 0.000 claims description 3
- 229940100460 peg-100 stearate Drugs 0.000 claims description 3
- 229920000058 polyacrylate Polymers 0.000 claims description 3
- 229940100458 steareth-21 Drugs 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims description 3
- ORUDEUCNYHCHPB-OUUBHVDSSA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-tetradecoxyoxane-3,4,5-triol Chemical compound CCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ORUDEUCNYHCHPB-OUUBHVDSSA-N 0.000 claims description 2
- NRTKYSGFUISGRQ-UHFFFAOYSA-N (3-heptanoyloxy-2,2-dimethylpropyl) heptanoate Chemical compound CCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCC NRTKYSGFUISGRQ-UHFFFAOYSA-N 0.000 claims description 2
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 claims description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 2
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 claims description 2
- YICVJSOYNBZJAK-UHFFFAOYSA-N 14-methylpentadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C YICVJSOYNBZJAK-UHFFFAOYSA-N 0.000 claims description 2
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 claims description 2
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 claims description 2
- QQGBDFMKLXCNHD-UHFFFAOYSA-N 2,2-bis(decanoyloxymethyl)butyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC QQGBDFMKLXCNHD-UHFFFAOYSA-N 0.000 claims description 2
- HFWHTGSLDKKCMD-UHFFFAOYSA-N 2,2-bis(octanoyloxymethyl)butyl octanoate Chemical compound CCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCC)COC(=O)CCCCCCC HFWHTGSLDKKCMD-UHFFFAOYSA-N 0.000 claims description 2
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 claims description 2
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 claims description 2
- VDHIEQOYPSVNIM-UHFFFAOYSA-N 2-hexyldecyl 2-ethylhexanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)C(CC)CCCC VDHIEQOYPSVNIM-UHFFFAOYSA-N 0.000 claims description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 claims description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 2
- DHFUFHYLYSCIJY-WSGIOKLISA-N CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O Chemical compound CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DHFUFHYLYSCIJY-WSGIOKLISA-N 0.000 claims description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 2
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 claims description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 claims description 2
- 241001072282 Limnanthes Species 0.000 claims description 2
- 241000144217 Limnanthes alba Species 0.000 claims description 2
- 241000208473 Macadamia ternifolia Species 0.000 claims description 2
- RGMZNZABJYWAEC-UHFFFAOYSA-N Methyltris(trimethylsiloxy)silane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C RGMZNZABJYWAEC-UHFFFAOYSA-N 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims description 2
- LPGFSDGXTDNTCB-UHFFFAOYSA-N [3-(16-methylheptadecanoyloxy)-2,2-bis(16-methylheptadecanoyloxymethyl)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC(C)C)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C LPGFSDGXTDNTCB-UHFFFAOYSA-N 0.000 claims description 2
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate group Chemical group C(C=C)(=O)[O-] NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 2
- 235000010290 biphenyl Nutrition 0.000 claims description 2
- 239000004305 biphenyl Substances 0.000 claims description 2
- 125000006267 biphenyl group Chemical group 0.000 claims description 2
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 claims description 2
- 229940095082 c13-15 alkane Drugs 0.000 claims description 2
- 229960001631 carbomer Drugs 0.000 claims description 2
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 2
- 229940074979 cetyl palmitate Drugs 0.000 claims description 2
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 claims description 2
- 229940090934 diphenylsiloxy phenyl trimethicone Drugs 0.000 claims description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 2
- XJFGDLJQUJQUEI-UHFFFAOYSA-N dodecyl decanoate dodecyl octanoate Chemical compound CCCCCCCCCCCCOC(=O)CCCCCCC.CCCCCCCCCCCCOC(=O)CCCCCCCCC XJFGDLJQUJQUEI-UHFFFAOYSA-N 0.000 claims description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 2
- 229940075529 glyceryl stearate Drugs 0.000 claims description 2
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 claims description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 claims description 2
- 229940100463 hexyl laurate Drugs 0.000 claims description 2
- 229940078568 isocetyl myristate Drugs 0.000 claims description 2
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 claims description 2
- 229940074928 isopropyl myristate Drugs 0.000 claims description 2
- 229940060384 isostearyl isostearate Drugs 0.000 claims description 2
- 229940071085 lauroyl glutamate Drugs 0.000 claims description 2
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 claims description 2
- 229940048848 lauryl glucoside Drugs 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- 229940073663 methyl trimethicone Drugs 0.000 claims description 2
- 229940043348 myristyl alcohol Drugs 0.000 claims description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 2
- 229940073665 octyldodecyl myristate Drugs 0.000 claims description 2
- 229940057874 phenyl trimethicone Drugs 0.000 claims description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 2
- 229940097941 polyglyceryl-10 laurate Drugs 0.000 claims description 2
- 229940100861 polyglyceryl-3 laurate Drugs 0.000 claims description 2
- 229940056099 polyglyceryl-4 oleate Drugs 0.000 claims description 2
- 229940057910 shea butter Drugs 0.000 claims description 2
- 229950011392 sorbitan stearate Drugs 0.000 claims description 2
- 229940032094 squalane Drugs 0.000 claims description 2
- 229940012831 stearyl alcohol Drugs 0.000 claims description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 2
- SCRSFLUHMDMRFP-UHFFFAOYSA-N trimethyl-(methyl-octyl-trimethylsilyloxysilyl)oxysilane Chemical compound CCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C SCRSFLUHMDMRFP-UHFFFAOYSA-N 0.000 claims description 2
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 241000221095 Simmondsia Species 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 claims 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 1
- 239000001534 FEMA 4201 Substances 0.000 claims 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 claims 1
- 240000000912 Macadamia tetraphylla Species 0.000 claims 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 claims 1
- 235000014121 butter Nutrition 0.000 claims 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 claims 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 229940061570 polyglyceryl-10 stearate Drugs 0.000 claims 1
- 235000020238 sunflower seed Nutrition 0.000 claims 1
- 239000006041 probiotic Substances 0.000 abstract description 9
- 235000018291 probiotics Nutrition 0.000 abstract description 9
- 235000013406 prebiotics Nutrition 0.000 abstract description 8
- 239000011149 active material Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 description 18
- 239000002552 dosage form Substances 0.000 description 16
- 230000001580 bacterial effect Effects 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 10
- 238000011156 evaluation Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000011081 inoculation Methods 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 125000000129 anionic group Chemical group 0.000 description 4
- 125000002091 cationic group Chemical group 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- NLMOQNHZOQGLSZ-UHFFFAOYSA-N heptyl undec-10-enoate Chemical compound CCCCCCCOC(=O)CCCCCCCCC=C NLMOQNHZOQGLSZ-UHFFFAOYSA-N 0.000 description 3
- 229940086561 heptyl undecylenate Drugs 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000008204 material by function Substances 0.000 description 3
- 229940023750 peg-60 glyceryl isostearate Drugs 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000006150 trypticase soy agar Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 2
- 241000736262 Microbiota Species 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940080421 coco glucoside Drugs 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000036074 healthy skin Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 229960002446 octanoic acid Drugs 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 2
- 230000000529 probiotic effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 230000036560 skin regeneration Effects 0.000 description 2
- LWBVAHQZGAKXPU-BOXHHOBZSA-M sodium;(4s)-4-amino-5-octadecoxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOC(=O)[C@@H](N)CCC([O-])=O LWBVAHQZGAKXPU-BOXHHOBZSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 229960000281 trometamol Drugs 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- MQFYRUGXOJAUQK-UHFFFAOYSA-N 2-[2-[2-(2-octadecanoyloxyethoxy)ethoxy]ethoxy]ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOC(=O)CCCCCCCCCCCCCCCCC MQFYRUGXOJAUQK-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- DDGPBVIAYDDWDH-UHFFFAOYSA-N 3-[dodecyl(dimethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC(O)CS([O-])(=O)=O DDGPBVIAYDDWDH-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241001340526 Chrysoclista linneella Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 244000147568 Laurus nobilis Species 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 229940019780 dipentaerythrityl hexa c5-9 acid esters Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940073551 distearyldimonium chloride Drugs 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 244000005702 human microbiome Species 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- NJTGANWAUPEOAX-UHFFFAOYSA-N molport-023-220-454 Chemical compound OCC(O)CO.OCC(O)CO NJTGANWAUPEOAX-UHFFFAOYSA-N 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 229940049292 n-(3-(dimethylamino)propyl)octadecanamide Drugs 0.000 description 1
- WWVIUVHFPSALDO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C WWVIUVHFPSALDO-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000013615 primer Substances 0.000 description 1
- 239000002987 primer (paints) Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 230000037070 skin defense Effects 0.000 description 1
- 230000008491 skin homeostasis Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- HSFQBFMEWSTNOW-UHFFFAOYSA-N sodium;carbanide Chemical group [CH3-].[Na+] HSFQBFMEWSTNOW-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/596—Mixtures of surface active compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Cosmetics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
本發明涉及對皮膚有益菌親和的組合物的用途。上述組合物可以作為化妝品而提供。The present invention relates to the use of compositions that are compatible with beneficial skin bacteria. The above composition can be provided as a cosmetic product.
最近數年間,消費者對有效保護因微塵、紫外線等外部刺激及壓力而受損或變弱的皮膚的「微生物組化妝品」的關注越來越高。In recent years, consumers have paid increasing attention to "microbiome cosmetics" that effectively protect skin that is damaged or weakened by external stimuli and stress such as dust and ultraviolet rays.
微生物組化妝品是指應用對人類皮膚上棲息的「皮膚常居菌(resident flora)」的生長產生直接或間接影響的材料,誘導皮膚的菌群(微生物群,microbiota)變化,從而能夠維持健康皮膚或改善皮膚狀態的化妝品。根據先行研究,皮膚常居菌在維持皮膚免疫系統以及保護皮膚免受包括病原菌在內的一些環境危害等方面發揮重要作用(Byrd, A. L.等人。(2018) Nature Reviews Microbiology, 16(3), 143)。因此,通過微生物組化妝品研究,可以維持皮膚上存在的常居菌群之間的平衡並營造有利於有益菌生長的環境,從而期待強化皮膚免疫力、減少痤瘡、改善皮膚屏障等的效果(S. Lebeer等人。(2018) BioRxiv. doi: doi.org/10.1101/463307)。Microbiome cosmetics refer to the application of materials that directly or indirectly affect the growth of "resident flora" that inhabit human skin, inducing changes in the skin's bacterial flora (microbiota), thereby maintaining healthy skin Or cosmetics that improve skin condition. According to prior research, skin-resident bacteria play an important role in maintaining the skin immune system and protecting the skin from some environmental hazards including pathogenic bacteria (Byrd, A. L. et al. (2018) Nature Reviews Microbiology, 16(3), 143). Therefore, through research on microbiome cosmetics, it is possible to maintain the balance between the resident flora present on the skin and create an environment conducive to the growth of beneficial bacteria, thereby strengthening skin immunity, reducing acne, improving the skin barrier, etc. (S . Lebeer et al. (2018) BioRxiv. doi: doi.org/10.1101/463307).
對具有這種特長的微生物組化妝品的市場需求不斷發生,跨國企業(MNC)為了研究微生物組化妝品,正在運營自己的研究所或通過與製藥公司合作開展多種研究。然而,目前微生物組化妝品研究集中在具有「益生元」或「益生菌」效果的功效材料的發掘及其應用上。There is a growing market demand for microbiome cosmetics with such expertise, and multinational corporations (MNCs) are running their own research institutes or conducting various studies in collaboration with pharmaceutical companies in order to study microbiome cosmetics. However, current research on microbiome cosmetics focuses on the discovery and application of functional materials with "prebiotic" or "probiotic" effects.
截至目前,研究上市的微生物組化妝品大部分以在一般化妝品劑型成分(增稠系、乳化系和水/內相穩定化所需的成分)中含有1)益生元(Prebiotics,通過誘導菌群變化或幫助有益菌的生存環境而賦予宿主益處的不可持續的飲食要素)和2)益生菌(Probiotics,賦予宿主益處並且其個體數維持適當量的同時共生的微生物)的產品為主,或者在較寬的範圍內也出現含有3)後生元(Postbiotics,由益生菌代謝或發酵等產生的物質)的產品。Up to now, most of the microbiome cosmetics researched and marketed contain 1) Prebiotics (Prebiotics) in general cosmetic dosage form ingredients (thickening system, emulsifying system, and ingredients required for water/internal phase stabilization), which induce changes in bacterial flora. or unsustainable dietary elements that help the living environment of beneficial bacteria and confer benefits to the host) and 2) probiotics (Probiotics, microorganisms that confer benefits to the host and maintain an appropriate number of individuals while living in symbiosis) products, or in relatively There are also a wide range of products containing 3) postbiotics (substances produced by the metabolism or fermentation of probiotics).
然而,上述益生元、益生菌和/或後生元等成分被電離或化學性質不明顯,與化妝品劑型成分的相容性差,其結果,為了高功效、高附加價值而過量使用時,劑型穩定性降低,從而可能出現析出、相分離。為了防止這種情況,大部分微生物組化妝品中益生元、益生菌和/或後生元成分的含量只能微乎其微。However, the above ingredients such as prebiotics, probiotics and/or postbiotics are ionized or have unclear chemical properties, and have poor compatibility with cosmetic dosage form ingredients. As a result, when used excessively for high efficacy and high added value, the stability of the dosage form will be compromised. decrease, resulting in possible precipitation and phase separation. To prevent this, most microbiome cosmetics contain only minimal amounts of prebiotic, probiotic and/or postbiotic ingredients.
另外,對於佔化妝品組合物的大部分的劑型成分,由於缺乏對微生物組的先行研究,對皮膚常居菌的影響和與功效成分的相互作用尚不清楚,因此在不考慮這些的情況下使用劑型成分時,存在不僅可能減輕功效成分的效果,甚至可能減輕化妝品的一般(保濕、鎮靜等)效果的問題。In addition, for dosage form ingredients that account for the majority of cosmetic compositions, due to the lack of prior research on the microbiome, the effects on skin-resident bacteria and interactions with functional ingredients are not yet clear, so they are used without taking these into consideration. When using ingredients in dosage forms, there is a problem that not only the effect of functional ingredients may be reduced, but also the general (moisturizing, calming, etc.) effects of cosmetics may be reduced.
在此背景下,本發明人為了確認不阻礙皮膚有益菌生長的劑型成分及其組成,經過不懈努力的結果,確認了在特定組成中不阻礙皮膚有益菌的生長,因此對皮膚有益菌親和,並將其應用於微生物組化妝品組合物中,從而完成了本發明。Against this background, the inventors of the present invention made unremitting efforts to confirm the ingredients and compositions of dosage forms that do not hinder the growth of skin-friendly bacteria. As a result, they confirmed that the specific composition does not hinder the growth of skin-friendly bacteria and is therefore compatible with skin-friendly bacteria. and applied it to a microbiome cosmetic composition, thereby completing the present invention.
[所欲解決之問題][Problem to be solved]
本發明的一個目的是提供一種用於維持或增強皮膚有益菌的化妝品組合物,其包含表面活性劑和油。It is an object of the present invention to provide a cosmetic composition for maintaining or enhancing beneficial skin bacteria, comprising a surfactant and an oil.
本發明的另一目的是提供一種用於維持皮膚內微生物組平衡的化妝品組合物,其包含表面活性劑和油。Another object of the present invention is to provide a cosmetic composition for maintaining the balance of the microbiome in the skin, which contains a surfactant and an oil.
本發明的又一目的是提供一種用於維持或增強皮膚有益菌的化妝品組合物的製備方法,包括:a)將表面活性劑溶解並分散的步驟;b)將油添加到上述分散的表面活性劑中並進行混合以製備混合物的步驟;以及c)將上述混合物投入純淨水中並進行乳化的步驟。 [解決問題之技術手段] Another object of the present invention is to provide a preparation method of a cosmetic composition for maintaining or enhancing skin beneficial bacteria, including: a) the steps of dissolving and dispersing a surfactant; b) adding oil to the dispersed surfactant into the agent and mix to prepare a mixture; and c) put the above mixture into purified water and emulsify. [Technical means to solve problems]
如下對本發明進行具體描述。同時,本發明中公開的各個描述和實施方式還可以應用於各個不同的描述和實施方式。即,本發明中公開的多種要素的所有組合均屬於本發明的範疇。另外,不能認為本發明的範疇由以下說明的具體敘述限制。The present invention will be described in detail below. At the same time, each description and embodiment disclosed in the present invention can also be applied to various different descriptions and embodiments. That is, all combinations of various elements disclosed in the present invention belong to the scope of the present invention. In addition, it is not considered that the scope of the present invention is limited by the specific description described below.
本發明的一個方面提供了一種用於維持或增強皮膚有益菌的化妝品組合物,其包含表面活性劑和油。One aspect of the invention provides a cosmetic composition for maintaining or enhancing beneficial skin bacteria, comprising a surfactant and an oil.
本發明的術語「皮膚有益菌」是指皮膚常居菌中的通過增強皮膚再生效果來增強皮膚防禦力、通過有害菌的細胞膜破壞(死亡)和生長抑制來增強皮膚再生、通過抑制炎症因子的表達來表現出鎮定皮膚和強化皮膚屏障的效果、表現出提高皮膚水分量和抑制水分流失的效果、通過使皮膚pH弱酸性化來改善pH環境從而幫助維持皮膚恆常性的菌株。上述皮膚有益菌可以是例如表皮葡萄球菌( Staphylococcus epidermidis)等,但不限於此。 The term "skin beneficial bacteria" in the present invention refers to bacteria resident in the skin that enhance skin defense by enhancing the skin regeneration effect, enhance skin regeneration by cell membrane destruction (death) and growth inhibition of harmful bacteria, and inhibit inflammatory factors. Expressed to show the effect of calming the skin and strengthening the skin barrier, showing the effect of increasing the moisture content of the skin and inhibiting water loss, and improving the pH environment by making the skin pH slightly acidic to help maintain skin homeostasis. The above-mentioned skin beneficial bacteria may be, for example, Staphylococcus epidermidis , but are not limited thereto.
本發明的化妝品組合物可以具有對皮膚有益菌親和的特性。The cosmetic composition of the present invention may have properties that are compatible with beneficial skin bacteria.
在本發明中,上述對皮膚有益菌親和的特性可以包括皮膚有益菌的維持和/或皮膚有益菌的增強。In the present invention, the above-mentioned affinity properties for skin beneficial bacteria may include maintenance of skin beneficial bacteria and/or enhancement of skin beneficial bacteria.
本發明的術語「維持皮膚有益菌」是指輔助前述皮膚有益菌的生長,使其維持一定個體數。就本發明的目的而言,上述皮膚有益菌的維持可以是表皮葡萄球菌的維持,但不限於此。The term "maintaining beneficial skin bacteria" in the present invention refers to assisting the growth of the aforementioned beneficial skin bacteria to maintain a certain number of individuals. For the purpose of the present invention, the maintenance of the above-mentioned skin beneficial bacteria may be the maintenance of Staphylococcus epidermidis, but is not limited thereto.
本發明的術語「增強皮膚有益菌」是指促進或改善前述皮膚有益菌的生長。就本發明的目的而言,上述皮膚有益菌的增強可以是表皮葡萄球菌的增強,但不限於此。The term "enhancing skin beneficial bacteria" in the present invention refers to promoting or improving the growth of the aforementioned skin beneficial bacteria. For the purpose of the present invention, the above-mentioned enhancement of beneficial skin bacteria may be the enhancement of Staphylococcus epidermidis, but is not limited thereto.
作為一例,在本發明中,使用「菌生長指數(index)」參數,將接種菌後第1天菌生長指數為-1.00以上的組合物選定為具有維持皮膚有益菌和/或增強皮膚有益菌的效果的「對皮膚有益菌親和的化妝品組合物」。As an example, in the present invention, the "bacterial growth index (index)" parameter is used to select a composition with a bacterial growth index of -1.00 or more on the first day after inoculation as having the ability to maintain skin beneficial bacteria and/or enhance skin beneficial bacteria. "Cosmetic composition that is friendly to beneficial skin bacteria".
即,本發明的化妝品組合物可以是包含表面活性劑和油的接種菌後第1天菌生長指數為-1.00以上的化妝品組合物。That is, the cosmetic composition of the present invention may contain a surfactant and oil and have a bacterial growth index of -1.00 or more on the first day after inoculation of the bacteria.
本發明的表面活性劑不限於此,但作為一例,可以是非離子性(Non-ionic)、磷脂質系(Phospholipid)和非磷脂質系(Non-Phospholipid)等,作為另一例,上述非磷脂質系表面活性劑可以是二月桂醯胺穀胺醯胺賴胺酸鈉(Sodium dilauramidoglutamide lysine)和菊粉月桂基胺基甲酸酯(Inulin lauryl carbamate)等,但不限於此。就本發明的目的而言,上述表面活性劑可以是非離子性、磷脂質系和/或非磷脂質系,但可以沒有限制地包括不阻礙有益菌生長的表面活性劑。The surfactant of the present invention is not limited to this, but as an example, it can be non-ionic (Non-ionic), phospholipid (Phospholipid), non-phospholipid (Non-Phospholipid), etc. As another example, the above-mentioned non-phospholipid The surfactant may be sodium dilauramidoglutamide lysine, inulin lauryl carbamate, etc., but is not limited thereto. For the purposes of the present invention, the above-mentioned surfactants may be non-ionic, phospholipid-based and/or non-phospholipid-based, but may include without limitation surfactants that do not hinder the growth of beneficial bacteria.
然而,在本發明的化妝品組合物中,不是非離子性、磷脂質系和非磷脂質系表面活性劑而是屬於陰離子性(Anionic)、陽離子性(Cationic)和兩親性(Amphoteric)的表面活性劑較佳地相對於本發明的化妝品組合物的總重量可以以1%以下包含,更佳地可以以0.1%以下包含,最佳地可以實質上不包含。However, in the cosmetic composition of the present invention, it is not non-ionic, phospholipid-based and non-phospholipid-based surfactants but surfaces belonging to anionic (Anionic), cationic (Cationic) and amphiphilic (Amphoteric) The active agent may preferably be included at 1% or less, more preferably at 0.1% or less, based on the total weight of the cosmetic composition of the present invention, and most preferably it may be substantially not included.
作為上述陰離子性表面活性劑的實例,有鯨蠟醇磷酸酯(Cetyl phosphate)等,具體地有鯨蠟醇磷酸酯鉀(Potassium cetyl phosphate)、鯨蠟醇磷酸酯精胺酸(Cetyl phosphate, arginine)、鯨蠟醇磷酸酯氫氧化鈉(Cetyl phosphate, sodium hydroxide)、鯨蠟醇磷酸酯胺丁三醇(Cetyl phosphate, tromethamine)、甲基硬脂醯基牛磺酸鈉(Sodium methyl stearoyl taurate)和硬脂醯基谷胺酸鈉(Sodium stearoyl glutamate)等,但不限於此。Examples of the anionic surfactant include cetyl phosphate, and specifically potassium cetyl phosphate, cetyl phosphate, arginine ), Cetyl phosphate, sodium hydroxide, Cetyl phosphate, tromethamine, Sodium methyl stearyl taurate and sodium stearyl glutamate (Sodium stearyl glutamate), etc., but are not limited thereto.
作為上述陽離子性表面活性劑的實例,有二硬脂基二甲基氯化銨(Distearyldimonium chloride)和硬脂醯胺丙基二甲胺(Stearamidopropyl dimethylamine)等,但不限於此。Examples of the above-mentioned cationic surfactant include distearyldimonium chloride and stearamidopropyl dimethylamine, but are not limited thereto.
作為上述兩親性表面活性劑的實例,有月桂基羥基磺基甜菜鹼(Lauryl hydroxysultaine)和椰油醯胺丙基甜菜鹼(Cocamidopropyl betaine)等,但不限於此。Examples of the above-mentioned amphiphilic surfactants include, but are not limited to, Lauryl hydroxysultaine and Cocamidopropyl betaine.
在本發明中,作為一例,非離子性表面活性劑可以是PEG(聚乙二醇,Polyethylene glycol)系和/或非-PEG(non-PEG)系等,但不限於此。In the present invention, as an example, the nonionic surfactant may be a PEG (Polyethylene glycol) system and/or a non-PEG (non-PEG) system, but is not limited thereto.
作為一例,上述PEG系非離子性表面活性劑可以是PEG-100硬脂酸酯(PEG-100 stearate)、硬脂醇聚醚-21 (Steareth-21)、PEG-40硬脂酸酯(PEG-40 stearate)和PEG-60氫化蓖麻油(PEG-60 hydrogenated castor oil)等,但不限於此。As an example, the above-mentioned PEG-based nonionic surfactant may be PEG-100 stearate (PEG-100 stearate), steareth-21 (Steareth-21), PEG-40 stearate (PEG -40 stearate) and PEG-60 hydrogenated castor oil (PEG-60 hydrogenated castor oil), etc., but are not limited thereto.
然而,作為上述PEG系非離子性表面活性劑,例如,聚山梨醇酯60(Polysorbate 60)、PEG-60甘油異硬脂酸酯(PEG-60 glyceryl isostearate)、PEG-11甲醚聚二甲基矽氧烷(PEG-11 methyl ether dimethicone)、PEG-10聚二甲基矽氧烷(PEG-10 dimethicone)和PEG-150二硬脂酸酯(PEG-150 distearate)等較佳地相對於本發明的化妝品組合物的總重量可以以1%以下包含,更佳地可以以0.1%以下包含,最佳地可以實質上不包含。However, as the above-mentioned PEG-based nonionic surfactant, for example, polysorbate 60 (Polysorbate 60), PEG-60 glyceryl isostearate (PEG-60 glyceryl isostearate), PEG-11 methyl ether polydimethyl PEG-11 methyl ether dimethicone, PEG-10 dimethicone and PEG-150 distearate are preferred relative to The total weight of the cosmetic composition of the present invention may be included at 1% or less, more preferably at 0.1% or less, and most preferably at substantially no amount.
作為一例,上述非-PEG系非離子性表面活性劑可以是甘油硬脂酸酯(Glyceryl stearate)、鯨蠟硬脂醇(Cetearyl alcohol)、鯨蠟硬脂基葡糖苷(Cetearyl glucoside)、脂肪醇類、烷基葡糖苷、山梨聚糖橄欖油酸酯(Sorbitan olivate)、鯨蠟硬脂醇橄欖油酸酯(Cetearyl olivate)、山梨聚糖硬脂酸酯(Sorbitan stearate)、蔗糖多硬脂酸酯(Sucrose polystearate)、鯨蠟醇棕櫚酸酯(Cetyl palmitate)、聚甘油油酸酯(Polyglyceryl oleate)、聚甘油月桂酸酯(Polyglyceryl laurate)和聚甘油硬脂酸酯(Polyglyceryl stearate)等,但不限於此。As an example, the non-PEG-based nonionic surfactant may be Glyceryl stearate, Cetearyl alcohol, Cetearyl glucoside, or fatty alcohol. Class, alkyl glucoside, Sorbitan olivate, Cetearyl olivate, Sorbitan stearate, Sucrose polystearate Sucrose polystearate, Cetyl palmitate, Polyglyceryl oleate, Polyglyceryl laurate and Polyglyceryl stearate, etc., but Not limited to this.
作為一例,上述脂肪醇類可以是月桂醇(Lauryl alcohol)、肉豆蔻醇(Myristyl alcohol)、鯨蠟醇(Cetyl alcohol)、硬脂醇(Stearyl alcohol)、花生醇(Arachidyl alcohol)、山崳醇(behenyl alcohol)和C14-22醇類(C14-22 alcohols)等,但不限於此。As an example, the above-mentioned fatty alcohols may be Lauryl alcohol, Myristyl alcohol, Cetyl alcohol, Stearyl alcohol, Arachidyl alcohol, Behenyl alcohol. (behenyl alcohol) and C14-22 alcohols (C14-22 alcohols), etc., but are not limited thereto.
作為一例,上述烷基葡糖苷可以是月桂基葡糖苷(Lauryl glucoside)、肉豆蔻基葡糖苷(Myristyl glucoside)、鯨蠟硬脂基葡糖苷(Cetearyl Glucoside)、花生基葡糖苷(Arachidyl glucoside)、C12-18烷基葡糖苷(C12-18 alkyl glucoside)和C12-20烷基葡糖苷(C12-20 alkyl glucoside)等,但不限於此。As an example, the alkyl glucoside may be Lauryl glucoside, Myristyl glucoside, Cetearyl Glucoside, Arachidyl glucoside, C12-18 alkyl glucoside (C12-18 alkyl glucoside), C12-20 alkyl glucoside (C12-20 alkyl glucoside), etc., but are not limited thereto.
作為一例,上述聚甘油油酸酯可以是聚甘油-2油酸酯(Polyglyceryl-2 oleate)、聚甘油-3油酸酯、聚甘油-4油酸酯、聚甘油-5油酸酯、聚甘油-6油酸酯、聚甘油-8油酸酯和聚甘油-10油酸酯等,但不限於此。As an example, the above-mentioned polyglyceryl oleate can be polyglyceryl-2 oleate (Polyglyceryl-2 oleate), polyglyceryl-3 oleate, polyglyceryl-4 oleate, polyglyceryl-5 oleate, polyglyceryl-5 oleate, Glyceryl-6 oleate, polyglycerol-8 oleate, polyglycerol-10 oleate, etc., but are not limited thereto.
作為一例,上述聚甘油月桂酸酯可以是聚甘油-2月桂酸酯(Polyglyceryl-2 laurate)、聚甘油-3月桂酸酯、聚甘油-4月桂酸酯、聚甘油-5月桂酸酯、聚甘油-6月桂酸酯和聚甘油-10月桂酸酯等,但不限於此。As an example, the above-mentioned polyglyceryl laurate may be polyglyceryl-2 laurate (Polyglyceryl-2 laurate), polyglyceryl-3 laurate, polyglyceryl-4 laurate, polyglyceryl-5 laurate, polyglyceryl laurate, polyglyceryl laurate, etc. Glyceryl-6 laurate, polyglyceryl-10 laurate, etc., but are not limited thereto.
作為一例,上述聚甘油硬脂酸酯可以是聚甘油-2硬脂酸酯(Polyglyceryl-2 stearate)、聚甘油-3硬脂酸酯、聚甘油-4硬脂酸酯、聚甘油-5硬脂酸酯、聚甘油-6硬脂酸酯、聚甘油-8硬脂酸酯和聚甘油-10硬脂酸酯等,但不限於此。As an example, the polyglyceryl stearate may be polyglyceryl-2 stearate, polyglyceryl-3 stearate, polyglyceryl-4 stearate, or polyglyceryl-5 stearate. Fatty acid ester, polyglycerol-6 stearate, polyglycerol-8 stearate, polyglycerol-10 stearate, etc., but are not limited thereto.
然而,作為上述非-PEG系非離子性表面活性劑,例如,椰油基葡糖苷(Coco-glucoside)等較佳地相對於本發明的化妝品組合物的總重量可以以1%以下包含,更佳地可以以0.1%以下包含,最佳地可以實質上不包含。However, as the above-mentioned non-PEG-based nonionic surfactant, for example, coco-glucoside (Coco-glucoside) and the like can be preferably contained in an amount of 1% or less based on the total weight of the cosmetic composition of the present invention, and more preferably Good land may be included at 0.1% or less, and optimal land may not be included substantially.
在本發明中,磷脂質系表面活性劑可以是卵磷脂(Lecithin)、氫化卵磷脂(Hydrogenated lecithin)等,但不限於此。In the present invention, the phospholipid surfactant may be lecithin, hydrogenated lecithin, etc., but is not limited thereto.
在本發明中,非磷脂質系表面活性劑可以是二月桂醯胺穀胺醯胺賴胺酸鈉(Sodium dilauramidoglutamide lysine)和菊粉月桂基胺基甲酸酯(Inulin lauryl carbamate)等,對此如前所述。In the present invention, the non-phospholipid surfactant may be sodium dilauramidoglutamide lysine, inulin lauryl carbamate, etc. As mentioned before.
本發明的油可以不是琥珀酸二乙氧基乙酯(Diethoxyethyl succinate)、雙乙氧基二甘醇環己烷1,4-二羧酸酯(Bis-ethoxydiglycol cyclohexane 1,4-Dicarboxylate)、十一烯酸庚酯(Heptyl undecylenate)、橄欖油(Olea europaea (OLIVE) fruit oil)或鱷梨油(Persea gratissima (avocado) oil)。具體地,上述琥珀酸二乙氧基乙酯、雙乙氧基二甘醇環己烷1,4-二羧酸酯、十一烯酸庚酯、橄欖油和鱷梨油等較佳地相對於本發明的化妝品組合物的總重量可以以1%以下包含,更佳地可以以0.1%以下包含,最佳地可以實質上不包含。除了前述油外,本發明的油可以沒有限制地包括不阻礙有益菌生長的油。The oil of the present invention may not be Diethoxyethyl succinate, Bis-ethoxydiglycol cyclohexane 1,4-Dicarboxylate, or Bis-ethoxydiglycol cyclohexane 1,4-Dicarboxylate. Heptyl undecylenate, Olea europaea (OLIVE) fruit oil or Persea gratissima (avocado) oil. Specifically, the above-mentioned diethoxyethyl succinate, diethoxydiglycol cyclohexane 1,4-dicarboxylate, heptyl undecenoate, olive oil, avocado oil, etc. are preferably relatively The total weight of the cosmetic composition of the present invention can be included at 1% or less, more preferably at 0.1% or less, and most preferably at not substantially included. In addition to the aforementioned oils, the oils of the present invention may include, without limitation, oils that do not hinder the growth of beneficial bacteria.
作為其實例,本發明的油可以是除前述油外的烴油(Hydrocarbon oil)、酯油(Ester oil)、矽油(Silicone oil)和天然油(Natural oil)等,但不限於此。As examples thereof, the oil of the present invention may be hydrocarbon oil, ester oil, silicone oil, natural oil, etc. in addition to the aforementioned oils, but is not limited thereto.
在本發明中,作為一例,烴油可以是C13-15烷(C13-15 alkane)、氫化聚癸烯(Hydrogenated polydecene)、氫化聚異丁烯(Hydrogenated polyisobutene)、異十二烷(Isododecane)、異十六烷(Isohexadecane)、角鯊烷(Squalane)、十一烷(Undecane)、十三烷(Tridecane)、C13-14烷(C13-14 Alkane)、C14-17烷(C14-17 Alkane)、C14-19烷(C14-19 Alkane)和C15-19烷(C15-19 alkane)等,但不限於此。In the present invention, as an example, the hydrocarbon oil may be C13-15 alkane, hydrogenated polydecene (Hydrogenated polydecene), hydrogenated polyisobutene (Hydrogenated polyisobutene), isododecane (Isododecane), isodecane Isohexadecane, Squalane, Undecane, Tridecane, C13-14 Alkane, C14-17 Alkane, C14 -19 alkane (C14-19 Alkane), C15-19 alkane (C15-19 alkane), etc., but are not limited thereto.
在本發明中,作為一例,酯油可以是鯨蠟醇乙基己酸酯(Cetyl ethylhexanoate)、己基癸醇乙基己酸酯(Hexyldecyl ethylhexanoate)、異鯨蠟醇肉豆蔻酸酯(Isocetyl myristate)、異十三醇異壬酸酯(Isotridecyl isononanoate)、季戊四醇四異硬脂酸酯(Pentaerythrityl tetraisostearate)、季戊四醇四乙基己酸酯(Pentaerythrityl tetraethylhexanoate)、三異辛酸甘油酯(Triethylhexanoin)、辛酸/癸酸甘油三酯(Caprylic/capric triglyceride)、椰油醇-辛酸酯/癸酸酯(Coco-caprylate/caprate)、碳酸二辛酯(Dicaprylyl carbonate)、植物甾醇/辛基十二醇月桂醯谷胺酸酯(Phytosteryl/octyldodecyl lauroyl glutamate)、三羥甲基丙烷三辛酸酯/三癸酸酯(Trimethylolpropane tricaprylate/tricaprate)、二聚季戊四醇六C5-9酸酯類(Dipentaerythrityl hexa C5-9 acid esters)、二異硬脂醇蘋果酸酯(Diisostearyl malate)、月桂酸己酯(Hexyl laurate)、新戊二醇二庚酸酯(Neopentyl glycol diheptanoate)、異硬脂酸乙酯(Ethyl isostearate)、肉豆蔻酸異丙酯(Isopropyl myristate)、異硬脂醇異硬脂酸酯(Isostearyl isostearate)和辛基十二醇肉豆蔻酸酯(Octyldodecyl myristate)等,但不限於此。In the present invention, as an example, the ester oil may be Cetyl ethylhexanoate, Hexyldecyl ethylhexanoate, or Isocetyl myristate. , Isotridecyl isononanoate, Pentaerythrityl tetraisostearate, Pentaerythrityl tetraethylhexanoate, Triethylhexanoin, Caprylic acid/caprylic acid Caprylic/capric triglyceride, Coco-caprylate/caprate, Dicaprylyl carbonate, Phytosterol/octyldodecanol laurel Phytosteryl/octyldodecyl lauroyl glutamate, Trimethylolpropane tricaprylate/tricaprate, Dipentaerythrityl hexa C5-9 acid esters ), Diisostearyl malate, Hexyl laurate, Neopentyl glycol diheptanoate, Ethyl isostearate, Meat Isopropyl myristate, Isostearyl isostearate, Octyldodecyl myristate, etc., but are not limited thereto.
然而,作為上述酯油,例如,琥珀酸二乙氧基乙酯、雙乙氧基二甘醇環己烷1,4-二羧酸酯和十一烯酸庚酯等較佳地相對於本發明的化妝品組合物的總重量可以以1%以下包含,更佳地可以以0.1%以下包含,最佳地可以實質上不包含。對此如前所述。However, as the above-mentioned ester oil, for example, diethoxyethyl succinate, diethoxydiglycol cyclohexane 1,4-dicarboxylate, heptyl undecenoate, etc. are preferred compared to the present invention. The total weight of the cosmetic composition of the invention may be included at 1% or less, more preferably at 0.1% or less, and most preferably not substantially included. As mentioned before about this.
在本發明中,作為一例,矽油可以是辛基聚甲基矽氧烷(Caprylyl methicone)、環六矽氧烷(Cyclohexasiloxane)、環五矽氧烷(Cyclopentasiloxane)、聚二甲基矽氧烷醇(Dimethiconol)、聚二甲基矽氧烷(Dimethicone)、甲基聚三甲基矽氧烷(Methyl trimethicone)、二苯基聚二甲基矽氧烷(Diphenyl dimethicone)、二苯基甲矽烷氧基苯基聚三甲基矽氧烷(Diphenylsiloxy phenyl trimethicone)和苯基聚三甲基矽氧烷(Phenyl trimethicone)等,但不限於此。In the present invention, as an example, the silicone oil may be Caprylyl methicone, Cyclohexasiloxane, Cyclopentasiloxane, or Dimethylsiloxane. (Dimethiconol), Dimethicone, Methyl trimethicone, Diphenyl dimethicone, Diphenyldimethicone Diphenylsiloxy phenyl trimethicone and phenyl trimethicone, etc., but are not limited thereto.
在本發明中,作為一例,天然油可以是葵花籽油(Helianthus annuus (sunflower) seed oil)、白池花籽油(Limnanthes alba (meadowfoam) seed oil)、澳洲堅果籽油(Macadamia ternifolia seed oil)、霍霍巴籽油(Simmondsia chinensis (jojoba) seed oil)、燕麥仁油(Avena sativa (oat) kernel oil)和牛油果樹果脂等,但不限於此。In the present invention, as an example, the natural oil may be Helianthus annuus (sunflower) seed oil, Limnanthes alba (meadowfoam) seed oil, Macadamia ternifolia seed oil, Simmondsia chinensis (jojoba) seed oil, Avena sativa (oat) kernel oil, shea butter, etc., but are not limited thereto.
然而,作為上述天然油,例如,橄欖油和鱷梨油等較佳地相對於本發明的化妝品組合物的總重量可以以1%以下包含,更佳地可以以0.1%以下包含,最佳地可以實質上不包含。對此如前所述。However, as the above-mentioned natural oil, for example, olive oil, avocado oil, etc. can be preferably contained at 1% or less, more preferably at 0.1% or less, based on the total weight of the cosmetic composition of the present invention, and most preferably It may not be included substantially. As mentioned before about this.
本發明的化妝品組合物可以進一步包含脂肪酸。The cosmetic composition of the present invention may further comprise fatty acids.
在本發明中,脂肪酸可以是肉豆蔻酸(Myristic Acid)、硬脂酸(Stearic Acid)和山崳酸(Behenic Acid)等,但可以沒有限制地包括不阻礙有益菌生長的脂肪酸。In the present invention, the fatty acid may be myristic acid, stearic acid, behenic acid, etc., but may include without limitation fatty acids that do not hinder the growth of beneficial bacteria.
本發明的化妝品組合物可以將前述油和/或脂肪酸分別以1個以上的成分添加。The cosmetic composition of the present invention may add the aforementioned oil and/or fatty acid as one or more components respectively.
本發明的化妝品組合物可以製備成選自由溶液、外用軟膏、霜、泡沫、營養化妝水、柔軟化妝水、面膜、柔膚水、乳液、妝前底乳、精華液、香皂、液體清潔料、入浴劑、防曬霜、防曬油、懸濁液、乳濁液、糊劑(paste)、凝膠、露、粉、皂、含有表面活性劑的清洗劑、油、粉末粉底、乳濁液粉底、蠟粉底、貼片和噴霧組成的組中的劑型,但不限於此。The cosmetic composition of the present invention can be prepared into a form selected from solutions, topical ointments, creams, foams, nutritious lotions, soft lotions, facial masks, toners, emulsions, makeup primers, essences, soaps, liquid cleansing materials, Bath agents, sunscreens, sunscreen oils, suspensions, emulsions, pastes, gels, lotions, powders, soaps, cleansers containing surfactants, oils, powder foundations, emulsion foundations, Dosage forms in the group consisting of, but not limited to, wax foundations, patches and sprays.
在本發明中,上述化妝品組合物可以進一步包含一種以上配入一般皮膚化妝品中的化妝品學上可接受的載體,作為常規成分,可以適當地配入例如油分、水、表面活性劑、保濕劑、低級醇、增稠劑、螯合劑、色素、防腐劑、香料等,但不限於此。In the present invention, the above-mentioned cosmetic composition may further contain one or more cosmetically acceptable carriers that are blended into general skin cosmetics. As conventional ingredients, oil, water, surfactants, moisturizers, etc. may be appropriately blended. Lower alcohols, thickeners, chelating agents, pigments, preservatives, flavors, etc., but are not limited to these.
作為一具體例,本發明的化妝品組合物可以進一步包含增稠劑。上述增稠劑可以是例如丙烯酸酯類/C10-30烷基丙烯酸酯交聯聚合物(Acrylates/C10-30 Alkyl Acrylate Crosspolymer)、卡波姆(Carbomer)、聚丙烯酸酯交聯聚合物-6 (Polyacrylate Crosspolymer-6)和黃原膠(Xanthan Gum)等,但不限於此。As a specific example, the cosmetic composition of the present invention may further include a thickener. The above-mentioned thickener can be, for example, acrylates/C10-30 Alkyl Acrylate Crosspolymer (Acrylates/C10-30 Alkyl Acrylate Crosspolymer), Carbomer, Polyacrylate Crosspolymer-6 ( Polyacrylate Crosspolymer-6) and Xanthan Gum (Xanthan Gum), etc., but are not limited to these.
作為另一具體例,本發明的化妝品組合物可以進一步包含維生素。上述維生素可以是例如泛醇(Panthenol)等,但不限於此。As another specific example, the cosmetic composition of the present invention may further contain vitamins. The above-mentioned vitamin may be, for example, Panthenol, but is not limited thereto.
本發明的化妝品組合物中包含的化妝品學上可接受的載體根據化妝品組合物的劑型而多樣。The cosmetically acceptable carrier contained in the cosmetic composition of the present invention varies depending on the dosage form of the cosmetic composition.
當本發明的劑型為軟膏、糊劑、霜、或凝膠時,作為載體成分,可以利用動物性油、植物性油、蠟(wax)、石蠟(paraffin)、澱粉、黃蓍膠、纖維素衍生物、聚乙二醇、矽酮、膨潤土、二氧化矽、滑石、氧化鋅等,但不限於此。這些可以單獨使用或兩種以上混合而使用。When the dosage form of the present invention is an ointment, paste, cream, or gel, as the carrier component, animal oil, vegetable oil, wax, paraffin, starch, tragacanth, and cellulose can be used Derivatives, polyethylene glycol, silicone, bentonite, silica, talc, zinc oxide, etc., but are not limited to these. These can be used individually or in mixture of 2 or more types.
當本發明的劑型為粉或噴霧時,作為載體成分,可以利用乳糖、滑石、二氧化矽、氫氧化鋁、矽酸鈣、聚醯胺粉等,特別是,當為噴霧時,可以附加地包含推進劑,例如氯氟烴、丙烷/丁烷或二甲醚,但不限於此。這些可以單獨使用或兩種以上混合而使用。When the dosage form of the present invention is powder or spray, as the carrier component, lactose, talc, silicon dioxide, aluminum hydroxide, calcium silicate, polyamide powder, etc. can be used. In particular, when it is a spray, it can be additionally Contains propellants such as, but not limited to, chlorofluorocarbons, propane/butane, or dimethyl ether. These can be used individually or in mixture of 2 or more types.
當本發明的劑型為溶液或乳濁液時,作為載體成分,可以利用溶劑、增溶劑或乳濁劑等,並且可以利用例如水、乙醇、異丙醇、碳酸乙酯、乙酸乙酯、苯甲醇、苯甲酸苄酯、丙二醇、1,3-丁二醇、棉籽油、花生油、玉米胚種油、蓖麻油、芝麻油、甘油脂肪族酯、聚乙二醇或脫水山梨醇的脂肪酸酯,但不限於此。這些可以單獨使用或兩種以上混合而使用。When the dosage form of the present invention is a solution or emulsion, as the carrier component, a solvent, a solubilizer or an opacifying agent can be used, and for example, water, ethanol, isopropyl alcohol, ethyl carbonate, ethyl acetate, benzene, etc. can be used. Methanol, benzyl benzoate, propylene glycol, 1,3-butanediol, cottonseed oil, peanut oil, corn germ oil, castor oil, sesame oil, fatty acid esters of glycerol, polyethylene glycol or sorbitan, But not limited to this. These can be used individually or in mixture of 2 or more types.
當本發明的劑型為懸濁液時,作為載體成分,可以利用諸如水、乙醇或丙二醇的液體稀釋劑,諸如乙氧基化異硬脂醇、聚氧乙烯山梨醇酯和聚氧乙烯脫水山梨醇酯的懸濁劑,微晶纖維素,偏氫氧化鋁,膨潤土,瓊脂或黃蓍膠等,但不限於此。這些可以單獨使用或兩種以上混合而使用。When the dosage form of the present invention is a suspension, as a carrier component, liquid diluents such as water, ethanol or propylene glycol, such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol esters and polyoxyethylene sorbitan may be utilized. Suspending agents of alcohol esters, microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tragacanth, etc., but are not limited to these. These can be used individually or in mixture of 2 or more types.
當本發明的劑型為皂時,作為載體成分,可以利用脂肪酸的鹼金屬鹽、脂肪酸半酯鹽、脂肪酸蛋白水解物(hydrolysate)、羥乙基磺酸鹽(isethionate)、羊毛脂衍生物、脂肪族醇、植物性油、甘油、糖等,但不限於此。這些可以單獨使用或兩種以上混合而使用。When the dosage form of the present invention is a soap, as the carrier component, alkali metal salts of fatty acids, fatty acid half-ester salts, fatty acid protein hydrolysates (hydrolysate), isethionate (isethionate), lanolin derivatives, fats can be utilized Alcohols, vegetable oils, glycerin, sugar, etc., but are not limited to these. These can be used individually or in mixture of 2 or more types.
本發明的化妝品組合物可以進一步包含純淨水。The cosmetic composition of the present invention may further contain purified water.
相對於組合物的總重量,本發明的化妝品組合物中包含的表面活性劑和油的每個成分的含量可以為約0.1至30重量%,具體地可以為約1至10重量%、約2至10重量%、約3至10重量%、約4至10重量%、約5至10重量%、約1至8重量%、約2至8重量%、約3至8重量%、約4至8重量%、約5至8重量%、約1至7重量%、約2至7重量%、約3至7重量%、約4至7重量%、約5至7重量%、約1至6重量%、約2至6重量%、約3至6重量%、約4至6重量%、約5至6重量%、約1至5重量%、約2至5重量%、約3至5重量%、約4至5重量%,但不限於此。Relative to the total weight of the composition, the content of each component of the surfactant and oil contained in the cosmetic composition of the present invention may be about 0.1 to 30% by weight, specifically about 1 to 10% by weight, about 2% by weight. to 10 wt%, about 3 to 10 wt%, about 4 to 10 wt%, about 5 to 10 wt%, about 1 to 8 wt%, about 2 to 8 wt%, about 3 to 8 wt%, about 4 to 8% by weight, about 5 to 8% by weight, about 1 to 7% by weight, about 2 to 7% by weight, about 3 to 7% by weight, about 4 to 7% by weight, about 5 to 7% by weight, about 1 to 6 % by weight, about 2 to 6 % by weight, about 3 to 6 % by weight, about 4 to 6 % by weight, about 5 to 6 % by weight, about 1 to 5 % by weight, about 2 to 5 % by weight, about 3 to 5 % by weight %, about 4 to 5% by weight, but not limited to this.
另外,相對於組合物的總重量,本發明的化妝品組合物中進一步包含的脂肪酸的每個成分的含量可以為約0.1至30重量%,具體地可以為約1至10重量%,但不限於此。In addition, relative to the total weight of the composition, the content of each component of the fatty acid further included in the cosmetic composition of the present invention may be about 0.1 to 30% by weight, specifically about 1 to 10% by weight, but is not limited to this.
在本發明中,術語「約(about)」可在特定數字值之前給出。本申請中使用的術語「約」不僅包括術語後面所記載的確切數字,還包括幾乎是該數字或接近於該數字的範圍。考慮到給出該數字的上下文,可以決定是否接近於所提到的具體數字或是否幾乎是該數字。作為一例,術語「約」可以指數字值的-10%至+10%範圍。作為另一例,術語「約」可以指給定數字值的-5%至+5%範圍。然而不限於此。In this disclosure, the term "about" may be given before a specific numerical value. The term "about" used in this application includes not only the exact number stated after the term, but also a range that is almost that number or close to that number. Whether it is close to the specific number mentioned or whether it is almost that number can be decided by taking into account the context in which the number is given. As an example, the term "about" may refer to a range of -10% to +10% of a numerical value. As another example, the term "about" may refer to a range of -5% to +5% of a given numerical value. However, it is not limited to this.
本發明中記載的所有成分較佳不超過化妝品安全標準等相關規定(韓國規定)、化妝品安全技術規範(中國規定)中規定的最大使用值。All ingredients described in the present invention preferably do not exceed the maximum usage value stipulated in relevant regulations such as cosmetic safety standards (Korean regulations) and cosmetic safety technical specifications (Chinese regulations).
本發明的另一方面提供了一種用於維持皮膚內微生物組平衡的化妝品組合物,其包含表面活性劑和油。Another aspect of the present invention provides a cosmetic composition for maintaining microbiome balance in the skin, comprising a surfactant and an oil.
這裡使用的術語如前所述。The terminology used here is as stated previously.
本發明的組合物可以進一步包含脂肪酸。The composition of the present invention may further comprise fatty acids.
另外,本發明的組合物可以進一步包含選自增稠劑或維生素中的任何一種以上。In addition, the composition of the present invention may further contain any one or more selected from thickeners and vitamins.
在本發明中,「微生物組(microbiome)」是微生物群(microbiota)和基因組(genome)的合成詞,是指共存於人類、動植物、土壤、海洋、湖泊、岩壁、大氣等的微生物群和基因組全部。其中,皮膚內微生物組是存在於皮膚內的微生物與微生物之間、宿主與微生物之間構成複雜相互關係的微生物群,是指人類微生物組的一部分。In the present invention, "microbiome" is a compound word of microbiota and genome, and refers to the microorganisms that coexist in humans, animals and plants, soil, oceans, lakes, rock walls, atmosphere, etc. The whole genome. Among them, the skin microbiome is a group of microorganisms that form a complex interrelationship between microorganisms and microorganisms and between hosts and microorganisms that exist in the skin. It refers to a part of the human microbiome.
上述「維持皮膚內微生物組平衡」是指促進皮膚內有益菌的活性和生存,同時抑制皮膚內有害菌的增殖和/或活性,從而適當地維持皮膚內微生物群的平衡。具體地,上述維持微生物組平衡可通過維持或增強皮膚有益菌來實現。在本發明中,上述皮膚有益菌可以是表皮葡萄球菌。The above-mentioned "maintaining the balance of the microbiome in the skin" refers to promoting the activity and survival of beneficial bacteria in the skin while inhibiting the proliferation and/or activity of harmful bacteria in the skin, thereby appropriately maintaining the balance of the microbiome in the skin. Specifically, the above-mentioned maintenance of microbiome balance can be achieved by maintaining or enhancing beneficial skin bacteria. In the present invention, the above-mentioned skin beneficial bacteria may be Staphylococcus epidermidis.
本發明的又一方面提供了一種用於維持或增強皮膚有益菌的化妝品組合物的製備方法。Yet another aspect of the present invention provides a method for preparing a cosmetic composition for maintaining or enhancing beneficial skin bacteria.
具體地,上述方法可以包括:a)將表面活性劑溶解並分散的步驟;b)將油添加到上述分散的表面活性劑中並進行混合以製備混合物的步驟;以及c)將上述混合物投入純淨水中並進行乳化的步驟。Specifically, the above method may include: a) a step of dissolving and dispersing the surfactant; b) adding oil to the above-mentioned dispersed surfactant and mixing to prepare a mixture; and c) putting the above mixture into a pure water and perform the emulsification step.
這裡使用的術語如前所述。The terminology used here is as stated previously.
上述a)步驟可以包括將表面活性劑溶解並分散的步驟。The above-mentioned step a) may include the step of dissolving and dispersing the surfactant.
上述溶解可以在高溫下進行,作為一例,根據各表面活性劑的活化溫度,可以在50℃至80℃的溫度範圍內進行,但不限於此。The above-mentioned dissolution can be performed at a high temperature. As an example, depending on the activation temperature of each surfactant, it can be performed in a temperature range of 50°C to 80°C, but it is not limited thereto.
作為一例,上述表面活性劑可以是非離子性、磷脂質系和非磷脂質系等,作為另一例,上述非磷脂質系表面活性劑可以是二月桂醯胺穀胺醯胺賴胺酸鈉和菊粉月桂基胺基甲酸酯等,但不限於此,對此如前所述。As an example, the above-mentioned surfactant may be non-ionic, phospholipid-based, non-phospholipid-based, etc. As another example, the above-mentioned non-phospholipid surfactant may be sodium dilaurylamine, glutamine lysine, and chrysanthemum. Powder lauryl carbamate, etc., but are not limited thereto, as described above.
上述b)步驟可以包括將油作為油溶性成分添加到上述a)步驟中分散的表面活性劑中並進行混合以製備混合物的步驟。The above step b) may include a step of adding oil as an oil-soluble component to the surfactant dispersed in the above step a) and mixing to prepare a mixture.
此時,上述表面活性劑和油的每個成分的添加量可以為約0.1至30重量%,具體地可以為約1至10重量%、約2至10重量%、約3至10重量%、約4至10重量%、約5至10重量%、約1至8重量%、約2至8重量%、約3至8重量%、約4至8重量%、約5至8重量%、約1至7重量%、約2至7重量%、約3至7重量%、約4至7重量%、約5至7重量%、約1至6重量%、約2至6重量%、約3至6重量%、約4至6重量%、約5至6重量%、約1至5重量%、約2至5重量%、約3至5重量%、約4至5重量%,但不限於此。At this time, the addition amount of each component of the above-mentioned surfactant and oil can be about 0.1 to 30% by weight, specifically about 1 to 10% by weight, about 2 to 10% by weight, about 3 to 10% by weight, About 4 to 10 wt%, about 5 to 10 wt%, about 1 to 8 wt%, about 2 to 8 wt%, about 3 to 8 wt%, about 4 to 8 wt%, about 5 to 8 wt%, about 1 to 7% by weight, about 2 to 7% by weight, about 3 to 7% by weight, about 4 to 7% by weight, about 5 to 7% by weight, about 1 to 6% by weight, about 2 to 6% by weight, about 3 To 6 wt%, about 4 to 6 wt%, about 5 to 6 wt%, about 1 to 5 wt%, about 2 to 5 wt%, about 3 to 5 wt%, about 4 to 5 wt%, but not limited to this.
上述油可以不是琥珀酸二乙氧基乙酯、雙乙氧基二甘醇環己烷1,4-二羧酸酯、十一烯酸庚酯、橄欖油或鱷梨油。除了前述油外,本發明的油可以沒有限制地包括不阻礙有益菌生長的油。The oil may not be diethoxyethyl succinate, diethoxydiglycol cyclohexane 1,4-dicarboxylate, heptyl undecenoate, olive oil, or avocado oil. In addition to the aforementioned oils, the oils of the present invention may include, without limitation, oils that do not hinder the growth of beneficial bacteria.
作為其實例,本發明的油可以是除前述油外的烴油、酯油、矽油和天然油等,但不限於此,對此如前所述。As examples thereof, the oil of the present invention may be hydrocarbon oils, ester oils, silicone oils, natural oils, etc. in addition to the aforementioned oils, but is not limited thereto, as described above.
上述b)步驟中可以進一步添加脂肪酸作為油溶性成分並進行混合,但不限於此。In the above step b), fatty acid may be further added as an oil-soluble component and mixed, but it is not limited thereto.
脂肪酸可以是肉豆蔻酸、硬脂酸和山崳酸等,但可以沒有限制地包括不阻礙有益菌生長的脂肪酸,對此如前所述。The fatty acid may be myristic acid, stearic acid, behenic acid, etc., but may include without limitation fatty acids that do not hinder the growth of beneficial bacteria, as described above.
上述b)步驟中可以將前述油和/或脂肪酸分別以1個以上的成分添加。In the step b) above, the oil and/or fatty acid may be added as one or more components respectively.
上述c)步驟可以包括將上述b)步驟的混合物投入純淨水中並進行乳化的步驟。The above-mentioned step c) may include the step of putting the mixture of the above-mentioned step b) into purified water and emulsifying.
具體地,可以將混合物緩慢地投入純淨水中使得總重量%達到100重量%,然後通過均質機乳化約1至10分鐘,但不限於此。Specifically, the mixture can be slowly poured into purified water so that the total weight % reaches 100 weight %, and then emulsified by a homogenizer for about 1 to 10 minutes, but is not limited thereto.
上述b)或c)步驟中可以通過進一步添加選自增稠劑或維生素中的任何一種以上來進行乳化,但不限於此。In the above step b) or c), emulsification can be performed by further adding any one or more selected from thickeners or vitamins, but is not limited thereto.
上述方法可以在上述c)步驟之後進一步包括將乳化的混合物冷卻後排出的步驟,但不限於此。The above method may further include the step of cooling and then discharging the emulsified mixture after step c) above, but is not limited thereto.
用本發明的方法製備的化妝品組合物可以具有包括維持或增強皮膚有益菌的效果在內的對皮膚有益菌親和的特性,並且可以具有維持皮膚內微生物組平衡的效果。 [發明功效] The cosmetic composition prepared by the method of the present invention may have properties that are compatible with beneficial skin bacteria, including maintaining or enhancing the effect of beneficial skin bacteria, and may have an effect of maintaining the balance of the microbiome in the skin. [Invention effect]
本發明的組合物不阻礙皮膚有益菌的生長,對皮膚有益菌親和,並且可以在不添加益生元或益生菌等的功效性材料的情況下維持或促進有益菌的生長,因此可以作為微生物組化妝品組合物而提供。The composition of the present invention does not hinder the growth of beneficial bacteria on the skin, is compatible with beneficial bacteria on the skin, and can maintain or promote the growth of beneficial bacteria without adding functional materials such as prebiotics or probiotics, so it can be used as a microbiome. Cosmetic compositions are provided.
本發明之又一實施方式提供一種包含表面活性劑及油之化妝品組合物之用途,其用以製備維持或增強皮膚有益菌之組合物。Yet another embodiment of the present invention provides the use of a cosmetic composition comprising a surfactant and an oil to prepare a composition that maintains or enhances beneficial skin bacteria.
本發明之又一實施方式提供一種包含表面活性劑及油之化妝品組合物之用途,其用以製備維持皮膚內微生物組平衡之組合物。Another embodiment of the present invention provides the use of a cosmetic composition comprising a surfactant and an oil to prepare a composition for maintaining the balance of the microbiome in the skin.
在下文中,將通過實施例更詳細地說明本發明。然而,這些實施例用於示例性地說明本發明,並且本發明的範圍不受這些實施例的限制,對於本發明所屬技術領域中具有通常知識者來說是顯而易見的。Hereinafter, the present invention will be explained in more detail by examples. However, these embodiments are used to illustrate the present invention, and the scope of the present invention is not limited by these embodiments, and it will be obvious to those with ordinary skill in the technical field to which the present invention belongs.
製備例Preparation example 1.1. 製備用於皮膚有益菌親和性評價的組合物Preparation of compositions for skin beneficial bacteria affinity assessment
為了對劑型成分中表面活性劑和油溶性成分的皮膚有益菌親和性評價,如下將組合物製備成水包油型分散相。In order to evaluate the affinity of surfactants and oil-soluble ingredients in the dosage form for beneficial skin bacteria, the composition was prepared into an oil-in-water dispersion phase as follows.
具體地,從如圖2所示按官能團對表面活性劑進行分類的共7個系列[非離子系(PEG(聚乙二醇,polyethylene glycol)、非-PEG)、離子系(陰離子、陽離子和兩親性)及其他(磷脂質、非磷脂質)]中選擇一種,計量後,根據各表面活性劑的活化溫度,在50℃至80℃的溫度範圍內溶解並分散。從如圖3a和圖3b所示按官能團對油溶性成分(油)進行分類的共4個系列[烴類、酯類、矽類、天然(自然來源)]中選擇最多4種成分,按每成分5重量%(本發明中最多20重量%)計量後,與表面活性劑混合並攪拌至均勻。將混合物緩慢地投入純淨水中使得總重量%達到100重量%,然後通過均質機乳化約5分鐘,冷卻後排出(圖1)。Specifically, surfactants are classified into seven series according to functional groups as shown in Figure 2 [nonionic (PEG (polyethylene glycol, non-PEG), non-PEG), ionic (anionic, cationic, and Amphipathic) and others (phospholipid, non-phospholipid)], after measurement, dissolve and disperse in the temperature range of 50°C to 80°C according to the activation temperature of each surfactant. Select up to 4 ingredients from a total of 4 series [hydrocarbons, esters, silicones, natural (natural origin)] that classify oil-soluble ingredients (oils) according to functional groups as shown in Figure 3a and Figure 3b. After measuring 5% by weight of the ingredients (up to 20% by weight in the present invention), mix with the surfactant and stir until uniform. The mixture was slowly poured into purified water until the total weight % reached 100% by weight, then emulsified by a homogenizer for about 5 minutes, cooled and then discharged (Figure 1).
實驗例Experimental example 1.1. 評價皮膚有益菌親和性Evaluate skin affinity for beneficial bacteria
對於上述製備例1中製備的各組合物作為親和性評價標準的有益菌選定為屬於革蘭氏陽性菌(Gram positive bacteria)的表皮葡萄球菌( Staphylococcus epidermidis, S. epidermidis)。表皮葡萄球菌作為多數存在於健康皮膚上的皮膚常居菌,是生成肽抗生素或PSM(酚溶性調節蛋白,Phenol-soluble modulins)等從而改善皮膚免疫以及幫助皮膚抵禦外部環境因素的代表性有益菌(Parlet, C. P.等人。(2019) Trends in microbiology, 27(6), 497-507)。對有益菌的親和性評價如下用挑戰性試驗方法(challenge test method)(Russell A. D., (2003), Int J Cosmet Sci., 25(3), 147-153)進行。 For each composition prepared in Preparation Example 1, the beneficial bacteria used as the affinity evaluation criteria were Staphylococcus epidermidis ( S. epidermidis ), which is a Gram positive bacterium. Staphylococcus epidermidis is a skin-resident bacterium that mostly exists on healthy skin. It is a representative beneficial bacterium that produces peptide antibiotics or PSM (phenol-soluble modulins), etc., thereby improving skin immunity and helping the skin resist external environmental factors. (Parlet, CP et al. (2019) Trends in microbiology, 27(6), 497-507). The affinity to beneficial bacteria was evaluated as follows using the challenge test method (Russell AD, (2003), Int J Cosmet Sci., 25(3), 147-153).
具體地,首先將表皮葡萄球菌在37℃下在TSA(胰蛋白酶大豆瓊脂,Tryptic Soy Agar)培養基中培養24小時,然後接種於所準備的上述製備例1中製備的50.0 g各組合物中,使其達到1x10 6~ 1x10 7CFU(菌落形成單位,Colony-forming unit)/ml。接種後渦旋或使用無菌棒使菌體均勻地混合在組合物中,接種後儲存在室溫下。考慮到使用化妝品等產品的週期、使用者的一般使用形態,將最長24小時設定為需要確認的時間點。在這種判斷下,接種經過24小時後,將接種菌體的1 ml組合物用0.85% NaCl溶液逐步稀釋,將100 μl各稀釋的溶液噴塗在TSA培養基上,然後在37℃下培養48小時後計數CFU。 Specifically, Staphylococcus epidermidis was first cultured in a TSA (Tryptic Soy Agar) medium at 37°C for 24 hours, and then inoculated into 50.0 g of each composition prepared in the above Preparation Example 1, Make it reach 1x10 6 ~ 1x10 7 CFU (colony-forming unit)/ml. After inoculation, vortex or use a sterile rod to evenly mix the bacteria in the composition, and store at room temperature after inoculation. Taking into account the usage cycle of cosmetics and other products and the general usage patterns of users, a maximum of 24 hours is set as the time point that needs to be confirmed. Under this judgment, 24 hours after inoculation, 1 ml of the composition to inoculate the bacterial cells was gradually diluted with 0.85% NaCl solution, 100 μl of each diluted solution was sprayed on the TSA medium, and then cultured at 37°C for 48 hours. Count CFU afterwards.
親和性評價標準如下,使用「菌生長指數*」參數,將接種菌後第1天菌生長指數為-1.00以上的組合物選定為具有維持皮膚有益菌或增強皮膚有益菌的效果的「皮膚有益菌親和化妝品」。The affinity evaluation criteria are as follows. Using the "bacterial growth index*" parameter, a composition with a bacterial growth index of -1.00 or more on the first day after inoculation is selected as a "skin-beneficial" composition that has the effect of maintaining skin beneficial bacteria or enhancing skin beneficial bacteria. Bacteria-friendly cosmetics".
*菌生長指數= log 10[{生存菌數(cfu/g)} / {接種菌數(cfu/g)}] * Bacterial growth index = log 10 [{number of viable bacteria (cfu/g)} / {number of inoculated bacteria (cfu/g)}]
其結果如圖2所示,確認了表面活性劑中離子性(陰離子系、陽離子系和兩親性)以及多數含PEG的表面活性劑急劇阻礙有益菌的生長。相反,作為非離子性表面活性劑PEG系或非-PEG系表面活性劑、磷脂質系表面活性劑和非磷脂質系表面活性劑(二月桂醯胺穀胺醯胺賴胺酸鈉(Sodium dilauramidoglutamide lysine)和菊粉月桂基胺基甲酸酯(Inulin lauryl carbamate))不阻礙有益菌的生長。As a result, as shown in Figure 2, it was confirmed that surfactants with ionic properties (anionic, cationic, and amphipathic) and many PEG-containing surfactants drastically inhibit the growth of beneficial bacteria. On the contrary, as non-ionic surfactants PEG-based or non-PEG-based surfactants, phospholipid-based surfactants and non-phospholipid-based surfactants (Sodium dilauramidoglutamide lysine) and inulin lauryl carbamate) do not hinder the growth of beneficial bacteria.
特別是,從上述結果觀察到在磷脂質系表面活性劑的情況下,維持或增強有益菌的效果顯著,從而確認適合於皮膚有益菌親和化妝品組合物。In particular, it was observed from the above results that the phospholipid-based surfactant has a significant effect of maintaining or enhancing beneficial bacteria, and thus it was confirmed that it is suitable for a cosmetic composition compatible with skin beneficial bacteria.
另外,如圖3a和圖3b所示,確認了作為油溶性成分中的油,琥珀酸二乙氧基乙酯(Diethoxyethyl succinate)、雙乙氧基二甘醇環己烷1,4-二羧酸酯(Bis-ethoxydiglycol cyclohexane 1,4-Dicarboxylate)、十一烯酸庚酯(Heptyl undecylenate)、橄欖油(Olea europaea (OLIVE) fruit oil)或鱷梨油(Persea gratissima (avocado) oil)阻礙有益菌的生長。相反,確認了烴油和矽油到第1~2天為止菌生長指數維持在-1.0以上,不阻礙有益菌生長。酯油和天然油雖有一些程度的差異,但菌生長指數大於-1.0,大部分不阻礙有益菌生長。In addition, as shown in Figures 3a and 3b, it was confirmed that the oils among the oil-soluble components were diethoxyethyl succinate, diethoxydiglycol cyclohexane 1,4-dicarboxylate Bis-ethoxydiglycol cyclohexane 1,4-Dicarboxylate, Heptyl undecylenate, Olea europaea (OLIVE) fruit oil) or avocado oil (Persea gratissima (avocado) oil) prevent beneficial effects growth of bacteria. On the contrary, it was confirmed that hydrocarbon oil and silicone oil maintained the bacterial growth index above -1.0 until the 1st and 2nd days and did not hinder the growth of beneficial bacteria. Although there are some differences between ester oil and natural oil, the bacterial growth index is greater than -1.0, and most of them do not hinder the growth of beneficial bacteria.
製備例Preparation example 2.2. 製備對皮膚有益菌親和的化妝品組合物Preparation of cosmetic compositions that are compatible with beneficial skin bacteria
用上述製備例1的方法製備包含基於上述實驗例1的結果經確認不阻礙有益菌生長的表面活性劑和油溶性成分的化妝品組合物,並以下表1的組成混合來製備實施例1、比較例1至3。A cosmetic composition containing surfactants and oil-soluble ingredients confirmed not to inhibit the growth of beneficial bacteria based on the results of Experimental Example 1 was prepared using the method of Preparation Example 1 above, and the composition of Table 1 below was mixed to prepare Example 1 and Comparison. Examples 1 to 3.
[表1]
實驗例Experimental example 2.2. 評價實施例Evaluation Example 11 、比較例, comparative example 11 至to 33 的皮膚有益菌親和性Skin friendly bacteria affinity
用上述實驗例1的方法進行上述製備例2中製備的實施例1、比較例1至3的化妝品組合物的皮膚有益菌親和性評價,其結果示於下表2和3中。The skin beneficial bacteria affinity evaluation of the cosmetic compositions of Example 1 and Comparative Examples 1 to 3 prepared in Preparation Example 2 was performed using the method of Experimental Example 1, and the results are shown in Tables 2 and 3 below.
[表2]
[表3]
如上表2和3所示,使用對有益菌親和的烴油和非離子性、磷脂質表面活性劑開發的實施例1的劑型不阻礙表皮葡萄球菌的生長,而比較例1至3的劑型阻礙表皮葡萄球菌的生長(圖4)。As shown in Tables 2 and 3 above, the dosage form of Example 1, developed using hydrocarbon oil and nonionic, phospholipid surfactants that are compatible with beneficial bacteria, did not hinder the growth of Staphylococcus epidermidis, whereas the dosage forms of Comparative Examples 1 to 3 did. Growth of Staphylococcus epidermidis (Fig. 4).
從上述實驗例的結果確認了實施例1不阻礙皮膚有益菌的生長,對皮膚有益菌親和,並且可以在不添加益生元或益生菌等的功效性材料的情況下維持或促進有益菌的生長,並且確認了可以將其作為微生物組化妝品組合物而提供。From the results of the above experimental examples, it was confirmed that Example 1 does not hinder the growth of beneficial bacteria on the skin, is compatible with beneficial bacteria on the skin, and can maintain or promote the growth of beneficial bacteria without adding functional materials such as prebiotics or probiotics. , and confirmed that it can be provided as a microbiome cosmetic composition.
基於以上說明,本發明所屬技術領域中具有通常知識者可以理解在沒有變更本發明的技術思想或者必要的特徵的情況下本發明還可以以其他具體方式實施。對此,應當理解,以上說明的實施例在所有的方面均為示例性的而非限制性的。本發明的範圍應被解釋為包括後述的申請專利範圍的意思以及範圍和從其均等概念匯出的所有的變更或者變形的方式,而不僅僅包括上述的詳細說明。Based on the above description, those with ordinary knowledge in the technical field to which the present invention belongs can understand that the present invention can also be implemented in other specific ways without changing the technical idea or necessary features of the present invention. In this regard, it should be understood that the embodiments described above are illustrative and not restrictive in all respects. The scope of the present invention should be construed to include the meaning and range of the patent claims described below and all modifications and variations derived from the concepts of equivalents thereof, and not only include the above detailed description.
[圖1]是用於皮膚有益菌親和性評價的組合物製備方法的模式圖。 [圖2]是示出根據對各表面活性劑的皮膚有益菌親和性評價的菌生長指數的圖。 [圖3a]和[圖3b]是示出根據對各油溶性成分(油)的皮膚有益菌親和性評價的菌生長指數(index)的圖。 [圖4]是示出對實施例1和比較例1至3的化妝品組合物的皮膚有益菌親和性評價結果的圖。 [Fig. 1] is a schematic diagram of a composition preparation method for evaluation of skin beneficial bacteria affinity. [Fig. 2] Fig. 2 is a graph showing bacterial growth index based on evaluation of skin-friendly bacteria affinity for each surfactant. [Fig. 3a] and [Fig. 3b] are graphs showing the bacterial growth index (index) based on the skin beneficial bacteria affinity evaluation for each oil-soluble component (oil). [Fig. 4] Fig. 4 is a graph showing the evaluation results of skin beneficial bacteria affinity of the cosmetic compositions of Example 1 and Comparative Examples 1 to 3.
Claims (33)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220066841A KR20230166629A (en) | 2022-05-31 | 2022-05-31 | Cosmetic composition with skin microbiome-friendly properties |
KR10-2022-0066841 | 2022-05-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW202348221A true TW202348221A (en) | 2023-12-16 |
Family
ID=88878138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW112120414A TW202348221A (en) | 2022-05-31 | 2023-05-31 | Cosmetic composition with skin microbiome-friendly properties |
Country Status (5)
Country | Link |
---|---|
US (1) | US20230381094A1 (en) |
JP (1) | JP2023177301A (en) |
KR (1) | KR20230166629A (en) |
CN (1) | CN117137814A (en) |
TW (1) | TW202348221A (en) |
-
2022
- 2022-05-31 KR KR1020220066841A patent/KR20230166629A/en unknown
-
2023
- 2023-05-26 JP JP2023087092A patent/JP2023177301A/en active Pending
- 2023-05-30 CN CN202310626454.9A patent/CN117137814A/en active Pending
- 2023-05-31 TW TW112120414A patent/TW202348221A/en unknown
- 2023-05-31 US US18/203,956 patent/US20230381094A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20230381094A1 (en) | 2023-11-30 |
KR20230166629A (en) | 2023-12-07 |
CN117137814A (en) | 2023-12-01 |
JP2023177301A (en) | 2023-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018216744A1 (en) | Cosmetic and skin protecting agent containing lactic acid bacterium | |
ES2639023T3 (en) | Lactobacillus paracasei to treat senescence spots and / or melasma | |
JP2009013128A (en) | Skin care preparation for external use and oral composition | |
WO2014104171A1 (en) | Skin-exterior anti-ageing composition and production method therefor | |
JP2008127341A (en) | Hydrolyzate of water-soluble polysaccharide derived from tremella fuciformis berk, and antioxidant and cosmetic or skin care preparation and food each containing the same | |
JP2019006725A (en) | Hyaluronic acid production promoter and cosmetics containing the same | |
JP4091824B2 (en) | Skin preparation | |
WO2014115726A1 (en) | Antibacterial composition | |
CN111803422B (en) | Oil control composition and application thereof | |
JP2020176067A (en) | Cosmetic or skin care external preparation containing phosphatidylinositol | |
JP2003277223A (en) | Matrix metalloprotease inhibitor and skin elasticity- retaining cosmetic | |
JP2012092078A (en) | Cosmetic or skin external preparation containing hydroxy nicotinic acid or derivative thereof | |
JP2012246324A (en) | External skin care preparation | |
JP2013056841A (en) | Accelerator for forming tight junction | |
KR101626471B1 (en) | Preventive composition of color change for natural pigment | |
TW202348221A (en) | Cosmetic composition with skin microbiome-friendly properties | |
JP2004137196A (en) | Emulsifying agent and cosmetic | |
JP2002275018A (en) | Skin care preparation | |
JP2020083771A (en) | Antibacterial or antiseptic | |
JP2001261568A (en) | Production accelerator of profilaggrin and/or filaggrin protein | |
JP2010047483A (en) | Collagen gel shrinkage-promoting agent | |
JP2007314427A (en) | Lipoic acid-containing complex | |
KR101572985B1 (en) | Cosmetic Compositions of Powder-type Containing Liquid Component with Astarxanthin | |
JP2004097999A (en) | Emulsifier and cosmetic | |
JP2022029111A (en) | Novel extract derived from microalgae |